Articles related to RISK MANAGEMENT

A national case-control study of 108,366 women found that prolonged use of injectable medroxyprogesterone acetate was associated with a 5.55-fold increased risk of intracranial meningioma requiring surgery (95% CI 2.27-13.56), while levonorgestrel IUDs showed no increased risk.

“Understanding which people are at increased risk of a first stroke and providing support to preserve heart and brain health can help prevent a first stroke.”

The case highlights the critical importance of thorough documentation and appropriate follow-up care, regardless of a patient’s age or statistical likelihood of serious conditions.

A cohort study of nearly 400,000 adults over 20 years found no association between multivitamin use and increased longevity, with daily users showing a 4% higher mortality risk.

A Swedish case-control study identified a 21% increased risk of malignant lymphoma in individuals with tattoos compared to controls, prompting the need for further research into tattoo ink composition and potential long-term health effects.

In a phase 2b trial, plozasiran significantly reduced fasting triglyceride levels at 24 weeks in patients with mixed hyperlipidemia, with the 50 mg quarterly dose achieving a mean reduction of 62.4 percentage points. This study highlights the potential of APOC3 inhibition as a therapeutic strategy for lipid management.